CONTACT
NAVARRA
+34 948 194 700
NAVARRA
×
INTRANET
PEOPLE FINDER
English
Español
WORK WITH US
INVESTOR AREA
/servlet/autocompletar/
Delete
DO YOU WANT TO HELP US?
ÚNETE A NUESTRO EQUIPO
ÁREA DE INVERSIÓN
About us
Universidad de Navarra Biomedical Campus
Research Center of the Clínica
Organization
Transparency Portal
Corporate Responsibility (Compliance)
Research
Diseases
Research divisions
Research groups
Technological platforms
Research and clinical trials
Research Staff
Human Resources Strategy for Researchers (HRS4R)
Scientific activity
Innovation
Pipeline
Patents
Entrepreneurship | Spin off
Collaboration with companies
Investor Area
Training
Master's Degrees
Doctorate Programs
Training stays
Training contracts and grants
Collaborate with us
How to collaborate
Collaboration projects
Collaborating companies
Transparency
News
News
Events
Scientific Report 2022-23
Health and Science
Home
>
News
>
News
Cima Universidad de Navarra news
Specialties
Choose by department
Adhesion and Metastasis
Adoptive Cell Therapy
Adoptive Cellular Therapy
Advanced Therapies for Pediatric Solid Tumors
Advanced Therapies for Rare Liver Diseases
Animal Models
Animal Production and Experimentation
Applied and Translational Onco-Immunology
Aptámeros y Química Médica
Aptamers
Atherothrombosis
Biobank
Biochemical Analysis and Cell Metabolism
Bioinformatics
Biomedical Engineering
Cancer Division
Cancer gene therapy
Cardiac Tissue Engineering
Cardiovascular Diseases
Combination Strategies for Translational Immunotherapy
Computational Biology and Translational Genomics
Cytokine-Based Therapeutics
Cytometry
DNA and RNA Medicine
Dynamics of the antitumor immune response
Enable Technologies
Epigenetics
Epilepsy
Gene Therapy for Hereditary Hearing Loss and AAV Engineering
Gene Therapy for Monogenic Encephalopathies
Gene Therapy for Rare Diseases
Gene Therapy in Neurological Diseases
Gene Therapy in Neurological Disorders
Gene Therapy in Parkinson's Disease
Gene Therapy of Renal Diseases and Study of N-terminal Acetylation of Proteins
Genomics Unit
Heart Failure
Hemato-Oncology
Hepatology
Hepatology: Liquid Biopsy and Carcinogenesis
Hepatology: Metabolism, Epigenetics and Carcinogenesis
Hepatology: Molecular Mechanisms and Targets in liver carcinogenesis
Hepatology: Porphyrias and Carcinogenesis
Image
Immune Therapies
Immunology and Immunotherapy
Immunomodulation and Tumor Microenvironment
In vivo Organ Generation by Stem Cells
Locoregional Immunotherapy Strategies in Peritoneal Carcinomatosis
Lungsearch: Lung cancer Screening, Early detection, biomarkers and new therapeutic targets
Lymphomas
Machine Learning in Biomedicine
Medicinal Chemistry
Micro-PET
Microbiome and Clinical Physiology
Microphysiological Systems and Quantitative Biology
Morphology
Myelodysplastic Neoplasia
Myeloid Pathology
Neuroscience
Next Generation Gene Delivery Technologies
Non-coding RNA and Biotechnology
Non-Coding RNA and Cancer Genome
Oncogenes and Effector Targets
Peptide
Physiological Control and Monitoring
Preclinical Models and Analysis Tools
Predictive Response Marker
Radioactive Facility
Radioimmunotherapy strategies for pediatric tumors
Regulación de la Expresión Génica
Renal Gene Therapy and Chimeric AAV Development
RNA and Senescence
RNA Biology and Therapy
Solid Tumor
Stress Responses and Liver Cancer Immunotherapy
Therapeutic Innovation
Therapeutic Innovation in Lung Cancer
Translational Hematology
Translational Immunomics in Hematological Neoplasms
Translational Oncology
Tumor Evasion and New Targets
Vaccine Development
Date from
Date to
Identifican un ARN que regula el metabolismo de las células senescentes
El estudio del Cima Universidad de Navarra abre nuevas vías a terapias contra el cáncer y el envejecimiento
June 10, 2025
Researchers develop a new ultrasensitive method that detects residual disease in the blood of patients with multiple myeloma
Scientists at the Cima Universidad de Navarra demonstrate that the combination of immunomagnetic beads and next-generation flow cytometry achieves unprecedented sensitivity
June 2, 2025
Pacientes con enfermedades raras y profesionales sanitarios comparten ciencia, autocuidado y horizontes vitales
La sede de Madrid de la Clínica Universidad de Navarra ha celebrado un taller participativo entre especialistas, pacientes con porfirias y familiares orientado a mejorar la calidad de vida de cada día
May 28, 2025
Un ‘andamio’ creado con terapia celular y bioingeniería mejora la calidad de vida de corazones infartados en modelos preclínicos
La Clínica Universidad de Navarra, con participación de investigadores del Cima Universidad de Navarra, ha liderado el proyecto BRAVE, que combina bioingeniería y medicina regenerativa para desarrollar un dispositivo de asistencia biológica probado en modelo preclínico
May 27, 2025
The Botín Foundation and the University join forces to promote new advanced cancer therapies
This alliance seeks to accelerate the delivery of innovative hematologic oncology treatments to patients.
May 23, 2025
Cancer Center Clínica Universidad de Navarra Receives European Accreditation for Offering Oncology Care that the EU Requires by 2030
The Organization of European Cancer Institutes has accredited the healthcare, research, and teaching quality of the Cancer Center Clínica Universidad de Navarra as a comprehensive cancer center, making it the first non-public center of its kind in Spain.
May 21, 2025
